Literature DB >> 1582116

Piroxicam and indomethacin suppositories for painful coxarthrosis.

H Ersmark1, B Tjornstrand, G Gudmundsson, H Düppe, M Fagerlund, B Jacobsson, G Ordeberg, L Wallinder.   

Abstract

Six orthopaedic clinics in Sweden made a comparison of the effects and side effects of Piroxicam (20 mg) and Indomethacin (100 mg) suppositories in 261 patients with painful coxarthrosis on the waiting list for total hip replacement (THR). The study was designed as a single blind study over 4 weeks. Amount of pain and range of motion was registered before the trial and compared with findings after 4 weeks, including reported side effects. Both drugs gave satisfactory pain relief without any appreciable variation on weightbearing or at rest. On the other hand, the trial showed a significant difference (p = 0.0033, Student's-test) between the two drugs as regards the frequency of side effects from the lower gastrointestinal tract, where piroxicam had a lower rate compared with indomethacin. No serious complications occurred; 16 patients dropped out, 8 in each group.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582116     DOI: 10.1007/bf02207081

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Piroxicam and naproxen in osteoarthritis: a clinical comparison.

Authors:  I F Goldie
Journal:  Eur J Rheumatol Inflamm       Date:  1981

2.  Piroxicam and naproxen in patients with osteoarthritis of the hip waiting for total hip replacement.

Authors:  A Alho; O Jaer; U Slungaard; I Holme
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

Review 3.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

4.  [Therapeutic action of Piroxicam administered rectally in rheumatic diseases. Controlled double-blind study].

Authors:  F Maccà; L Milani; M Dal Follo; L Corbetta; G Zeni; R Zuin
Journal:  Minerva Med       Date:  1984-04-07       Impact factor: 4.806

5.  Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazone.

Authors:  P Schiantarelli; S Cadel
Journal:  Arzneimittelforschung       Date:  1981

6.  Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients.

Authors:  G Heynen; P Dessain
Journal:  Eur J Rheumatol Inflamm       Date:  1983
  6 in total
  2 in total

1.  Suppositories for arthritis.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

Review 2.  Current pharmacological treatment of osteoarthritis.

Authors:  F A Wollheim
Journal:  Drugs       Date:  1996       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.